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INTRODUCTION
Pelizaeus-Merzbacher disease (PMD) is a rare, X-linked reces-
sive dysmyelinating leukodystrophy of the central nervous sys-
tem (CNS). It is caused by mutations in the proteolipid pro-
tein 1 (PLP1) gene on the long arm of the X chromosome in
band Xq22 that encodes a major component of CNS myelin
protein (1, 2). There are several related tests available for the
diagnosis of PMD; however, no definitive test exists. In spite
of this, molecular testing of PLP1 is now essential to confirm
diagnosis. Here, we present a Korean boy with PMD who
had clinical symptoms mimicking cerebral palsy and was
confirmed to have a PLP1 duplication mutation using a spe-
cific molecular technique.
CASE REPORT
A 52-month-old boy with developmental delay was admit-
ted to the department of rehabilitation medicine for evalua-
tion and treatment. He was born post-maturely at the ges-
tational age of 41 weeks with an initial body weight of 3,400
g. The mother underwent a cesarean section due to failure of
progression during labor; however, the pregnancy and prena-
tal period of the patient had been uneventful. The boy showed
significantly delayed development. He could turn over and
pull-to-stand, but he could not stand without support. Also,
genu recurvatum was observed while standing. He could not
walk nor keep balance in a sitting position. His kneeling and
crawling were inadequate. He could not speak any meaning-
ful word. Physical examination showed horizontal nystagmus,
saccadic gaze, intentional tremor, head titubation, and atax-
ia. The deep tendon reflexes were hyperactive in all extremi-
ties and positive ankle clonus was observed, bilaterally. Elec-
tromyography was normal but somatosensory evoked poten-
tial showed no response on median nerve stimulation. Crea-
tine phosphokinase was normal and lactic dehydrogenase was
slightly increased (525 IU/L). Thyroid function tests, liver
function tests, and infant hereditary metabolic screening tests
(very-long-chain fatty acid, lactic acid, pyruvic acid, taurine
acid, urine organic acid, mucopolysaccharide, urine and serum
amino acids) were also normal. The brain magnetic resonance
image (MRI) studies revealed diffuse abnormal high signal
intensities in the white matter tract including observation
of subcortical U fiber on the T2-weighted and fluid attenu-
ated inversion recovery (FLAIR) image (Fig. 1). The pattern
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Identification of Proteolipid Protein 1 Gene Duplication by Multiplex
Ligation-Dependent Probe Amplification: First Report of Genetically
Confirmed Family of Pelizaeus-Merzbacher Disease in Korea
Pelizaeus-Merzbacher disease (PMD) is a rare X-linked recessive disorder with a
prototype of a dysmyelinating leukodystrophy that is caused by a mutation in the
proteolipid protein 1 (PLP1) gene on the long arm of the X chromosome in band
Xq22. This mutation results in abnormal expression or production of PLP. We here
present a Korean boy with spastic quadriplegia, horizontal nystagmus, saccadic
gaze, intentional tremor, head titubation, ataxia, and developmental delay. The
brain magnetic resonance imaging (MRI) showed abnormally high signal intensi-
ties in the white matter tract, including a subcortical U fiber on the T2-weighted and
fluid attenuated inversion recovery (FLAIR) image. The chromosomal analysis was
normal; however, duplication of the PLP1 gene in chromosome Xq22 was detect-
ed when the multiplex ligation-dependent probe amplification (MLPA) method was
used. We also investigated the pedigree for a genetic study related to PMD. This
case suggests that the duplication mutation of the PLP1 gene in patients with PMD
results in a mild clinical form of the disorder that mimics the spastic quadriplegia of
cerebral palsy.
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of the demyelination, which manifested as high SI on T2-
weighted or FLAIR images, was patchy, with characteristic
sparing of perivascular white matter creating a ‘‘tigroid’’ or
‘‘leopard-skin’’ pattern. There was no abnormal enhancement
found during a gadolinium-enhanced study. The overlying
cortex was normal.
His younger brother, a 27-month-old boy at present with
developmental delay, visited our outpatient clinic. The boy
revealed also significant developmental delay. He could creep,
but could not sit without support and, could not pull to sit.
He showed poor sitting balance while in the sitting posi-
tion. On physical examination, he also showed horizontal
nystagmus, saccadic gaze, rhythmic tremor, and head titu-
bation. The deep tendon reflexes were brisk in all extremi-
ties and positive ankle clonus was observed, bilaterally. He
was also unable to say any meaningful words.
After obtaining informed consent, blood samples were
collected from the patient, his parents and younger brother
for a genetic study. The genomic DNA was isolated from
peripheral blood leukocytes using a Wizard genomic DNA
purification kit according to the manufacturer’s instructions
(Promega, Madison, WI, U.S.A.). We used multiple liga-
tion-dependent probe amplification (MLPA) to screen all
exons of the PLP1 gene using a MLPA kit (SALSA P022;
MRC Holland, Amsterdam, Netherlands). The kit contains
a total of 32 probes, including 1 probe for each of the 7 PLP1
exons, 8 control probes of other parts of the X chromosome,
1 probe that detects a Y-chromosome, and 16 probes that
detect sequences on autosomes. All thermal reactions were
carried out on a thermal cycler (Model 9700, Applied Biosys-
tems, Foster City, CA, U.S.A.). One hundred nanograms of
sample DNA were diluted to 5  L with deionized water and
denaturated at 98℃ for 5 min before the addition of 3  L
MLPA probe mix and buffer. The reaction mixture was denat-
urated for 1 min, then incubated for 16 hr at 60℃to ensure
specific hybridization of the oligonucleotide probes with their
target sequences. After hybridization, a buffer/ligase mixture
(32  L) was added according to the manufacturer’s instruc-
tions and incubated at 54℃ for another 15 min to stabilize
the ligation reaction. Ligation was terminated by heating to
98℃ for 5 min. A fluorescent multiplex polymerase chain
reaction (PCR) amplification using a single universal primer
pair suitable for all 40 probes in each kit was carried out under
standard conditions (annealing temperature 60℃, 36 cycles).
PCR products were analyzed on a fluorescent capillary sequ-
encer (ABI 3100, Applied Biosystems, Foster City, CA, U.S.A.)
using Genescan software. Five healthy female control sam-
ples were included in each MLPA test to calibrate unknown
samples. Data analysis was performed with GeneMarker
�
software (SoftGenetics LLC, State College, PA 16803, U.S.A.).
The PLP1 gene dosage was determined using a population
normalization method. Expected PLP1 values for non-PMD
males, non-PMD females, males with a PLP1 duplication,
and female carriers of a PLP1 duplication are 0.5, 1.0, 1.0
and 1.5, respectively. 
We determined the relative PLP1 copy numbers from peak
areas by normalizing each PLP1 probe to each autosome, using
normal female DNA as a calibrator. The patient and younger
brother had all 7 PLP1 exons duplicated. His father showed
normal relative copy numbers of the PLP1 gene but his moth-
Fig. 1. Axial T2-weighted (A) and FLAIR (B) brain MRI scans at the level of the centrum semiovale in a 52-month-old boy with PMD. Exten-
sive high signal intensity in white matter including subcortical U fiber is seen. Note the residual myelinated fibers (arrows), showing iso-
signal intensity and giving the ‘‘tigroid’’ appearance sometimes presented in PMD, within the diffuse demyelinating white matter.
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er showed findings consistent with carriers of a duplication.
The relative dosage of PLP1 exons in the patient and his fam-
ily members are summurized in (Fig. 2). Taken together, these
findings indicate the patient and his younger brother could
be diagnosed with PMD caused by duplicated PLP1 gene,
inherited from their carrier mother.
DISCUSSION
Clinical findings in cases of PMD are very different and few
studies have been reported. Golomb et al. conducted a study
of 10 boys and reported their clinical findings (3). They found
that prenatal complication occurred in eight patients and
that their patients demonstrated defect of social interaction,
dysphasia, nystagmus, hypotonia, and spasticity, that affect-
ed the legs more than the arm, as well as ataxia. The patient
in our study demonstrated horizontal nystagmus, saccadic
gaze, intentional tremor, head titubation, and ataxia. The
deep tendon reflexes were hyperactive in all extremities.
Unlike general cases, the leg and arm were equally involved
and frequently showed spastic quadriplegia as seen in cases
of cerebral palsy, and initially, our clinics suspected that the
boy had spastic quadriplegia due to cerebral palsy. We focus-
ed on clinical diagnosis such as spasticity, inability to walk,
and MRI findings around the periventricular white matter.
The patient in our study showed only mild spasticity and
genu recurvaturm. Due to mild spasticity, the patient did
not show equines of foot or contracture of hip adductors,
which have been frequently shown in spastic quadriplegic
type cerebral palsy.
PMD has been reported several times in Korea since 1995,
but they were diagnosed by the clinical features and MRI
findings (4-6). In 2004, the first Korean case of PMD with a
confirmed point mutation in PLP1 was reported (7); howev-
er, aside from this case, there have been no reports of confirma-
tion based on a genetic study. 
Barkovich (8) suggested that in PMD, MR imaging showed
reduction of normal myelin and normal oligodendroglial cells
in the brain, resulting in delayed myelination. Due to the
marked reduction of myelin, both diffusion anisotropy and
magnetization transfer were decreased compared to age-ma-
tched control subjects. Our case showed abnormally high sig-
nal intensities in the white matter tract, including subcorti-
cal new fiber on the T2-weighted and FLAIR image, which
indicates abnormal myelination of white matter in the brain.
Complete duplication of the PLP1 gene on Xq22 is the
cause of 60-70% of PMD cases, whereas deletions of this gene
as well as point mutations in coding or splice site regions are
involved in most of the remaining cases. Duplications of PLP,
indicating an increased PLP1 dosage, prevent them from
making normal myelination. Patients with an increased
PLP1 dosage have variable phenotype ranging from severe
connatal to mild PMD, but most have a classic form of dis-
ease. Carrier females with a PLP1 duplication are usually
asymptomatic (9).
Various methods have been used to identify PLP1 gene du-
plications, including fluorescent in situ hybridization (FISH)
(10), array comparativ genomic hybridization (CGH) (11),
quantitative PCR (12), MLPA (13), real-time PCR (14), and
multiplex amplification and probe hybridization (MAPH)
(15). MLPA is based on the ligation of 2 adjacent annealing
oligonucleotides followed by quantitative PCR amplification
of the ligated products. Previous studies have confirmed the
efficiency of MLPA for detecting PLP1 gene duplications and
deletions with good intra- and interassay precision (16). The
precision of MLPA analysis was excellent and comparable to
or better than quantitative real-time PCR, with CVs of 4.3-
9.8% and 3.0-14%, respectively. Furthermore, MLPA analy-
sis using customized probe sets has proven to have signifi-
cant advantages over other methods such as FISH or array-
CGH or MAPH as a rapid, reliable, economical, and easy mo-
lecular test (17-19).
In summary, this is the first reported Korean case of PMD
in two affected male siblings with a confirmed duplication
of the PLP1 gene, inherited from their mother, an asymp-
Fig. 2. Multiplex ligation-dependent probe amplification (MLPA) results. (A) Electropherograms after MLPA analysis of the family. All peaks
corresponding to the 7 exons of the PLP1 gene in the proband and his brother are higher than peaks in the proband s father but similar
to peaks in female control due to PLP1 gene duplication. The proband s mother has even higher peaks than female control. (B) The rela-
tive copy numbers for each PLP1 exon were shown.
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tomatic carrier. Family study of the PLP1 gene in Korean
patients with suspected PMD, therefore, should be consid-
ered to better understand the mechanism of genetic disor-
ders as well as for counseling and family planning.
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